GGrantIndex
Sort

85,873 grants matching alzheimers

Adaptive Testing of Cognitive Function based on multi-dimensional Item Response Theory

$836,211
Robert D Gibbons · University Of Chicago · R56 · FY2019 · AG

Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD

$836,154
Rita Sattler · St. Joseph'S Hospital And Medical Center · R01 · FY2021 · NS

Optimal Medication Management in Alzheimer's Disease and Dementia

$836,138
Elizabeth A Bayliss · Kaiser Foundation Research Institute · R33 · FY2019 · AG

Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease

$836,123
Yu-Shin Ding · New York University School Of Medicine · R01 · FY2022 · AG

PET radiotracers to image the enzyme 11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD1)

$836,039
Yiyun Henry Huang · Yale University · R56 · FY2018 · MH

Predictors of Severity in Alzheimer's Disease

$836,002
Yaakov Stern · Columbia University Health Sciences · R01 · FY2006 · AG

Core A: Administrative Core

$836,002
James B Brewer · University Of California, San Diego · P30 · FY2024 · AG

Omics Analyses of HIV and Substance Use Disorder

$835,968
Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2023 · DA

Dominantly Inherited Alzheimer Network: Imaging Core

$835,967
Tammie Lee Smith Benzinger · Washington University · U19 · FY2020 · AG

Sleep Impairment: A Mechanism Explaining Neuropsychiatric Symptoms in Alzheimer's

$835,917
Matthew Paul Walker · University Of California Berkeley · R01 · FY2021 · MH

The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort

$835,875
Michael D Greicius · Stanford University · R01 · FY2018 · AG

Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related Dementias

$835,868
Rhoda Au · Boston University Medical Campus · R01 · FY2024 · AG

Caregiving for Alzheimer's Disease and Related Dementias: Enhancing the National Study of Caregiving (NSOC)

$835,842
Judith Kasper · Johns Hopkins University · R01 · FY2017 · AG

Single-cell analysis of DNA damage, somatic mutation, and gene expression in human Alzheimer’s disease brain

$835,825
Michael Anthony Lodato · Univ Of Massachusetts Med Sch Worcester · R56 · FY2023 · AG

Tau, amyloid, & white matter burden interact to impact brain networks in preclinical Alzheimer’s disease

$835,745
Julius C Hedden · Massachusetts General Hospital · R01 · FY2016 · AG

Neuroimaging Core

$835,610
Kejal Kantarci · Mayo Clinic Rochester · U19 · FY2023 · AG

Neuroimaging Core

$835,610
Kejal Kantarci · Mayo Clinic Rochester · U19 · FY2024 · AG

Neuroimaging Core

$835,610
Kejal Kantarci · Mayo Clinic Rochester · U19 · FY2020 · AG

Neuroimaging Core

$835,609
Kejal Kantarci · Mayo Clinic Rochester · U19 · FY2021 · AG

Genomic approach to identification of microglial networks involved in Alzheimer disease risk

$835,533
Alison M Goate · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · AG

Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease

$835,492
Elaine R. Peskind · University Of Washington · T32 · FY2025 · AG

Age-related Hypertension and Vascular Cognitive Impairment

$835,492
Richard David Wainford · Boston University Medical Campus · R01 · FY2022 · AG

Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes

$835,491
Carol A. Tamminga · Ut Southwestern Medical Center · R01 · FY2007 · MH

Probing Heterogeneity of Alzheimer's Disease Using iPSCs

$835,443
Tracy L Young-Pearse · Brigham And Women'S Hospital · R01 · FY2024 · AG

Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimer's Disease

$835,424
Mark W Albers · Massachusetts General Hospital · R56 · FY2017 · AG